Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Show Display Options
Rank Status Study
1 Not yet recruiting Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease
Condition: Sedentary Lifestyle
Interventions: Device: ActivPAL inclinometer;   Behavioral: Phone counseling call: Breaking up sitting time;   Behavioral: In-person counseling: Breaking up sitting time;   Behavioral: Phone counseling call: Healthy living;   Other: Tools to prompt standing;   Behavioral: In-person counseling: Healthy living
2 Recruiting Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation;   Atrial Arrhythmia
Interventions: Procedure: Circumferential Pulmonary Vein Ablation;   Procedure: Segmental Pulmonary Vein Isolation
3 Recruiting Substrate Versus Trigger Ablation for Paroxysmal Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
4 Recruiting AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
Conditions: Atrioventricular Block;   Sick Sinus Syndrome;   Symptomatic Bradycardia;   Cardiac Arrhythmia
Interventions: Device: Long, fixed AV delay;   Device: Short, optimized AV delay
5 Recruiting Adaptive Servo-Ventilation In Acute Heart Failure Patients Protecting the Heart and Kidneys
Conditions: Heart Failure;   Sleep Apnea, Obstructive
Intervention: Device: Adaptive Servo-Ventilation
6 Recruiting Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention: Procedure: CorPath-assisted Percutaneous Coronary Intervention
7 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
8 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.